| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| STILLWELL KENNETH | COO, CFO | C/O PEGASYSTEMS INC., 225 WYMAN STREET, STE 300, WALTHAM | /s/Kathryn Leach, Attorney-in-Fact for Kenneth Stillwell | 09 Dec 2025 | 0001680115 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PEGA | Common stock | Options Exercise | $0 | +4,402 | +3.4% | $0.000000 | 134,352 | 05 Dec 2025 | Direct | F1 |
| transaction | PEGA | Common stock | Tax liability | $98,781 | -1,733 | -1.3% | $57.00 | 132,619 | 05 Dec 2025 | Direct | |
| transaction | PEGA | Common stock | Options Exercise | $940,943 | +29,240 | +22% | $32.18 | 161,859 | 05 Dec 2025 | Direct | |
| transaction | PEGA | Common stock | Options Exercise | $621,000 | +20,000 | +12% | $31.05 | 181,859 | 05 Dec 2025 | Direct | |
| transaction | PEGA | Common stock | Tax liability | $2,062,547 | -35,833 | -20% | $57.56 | 146,026 | 05 Dec 2025 | Direct | |
| transaction | PEGA | Common stock | Sale | $452,758 | -7,821 | -5.4% | $57.89 | 138,205 | 05 Dec 2025 | Direct | |
| transaction | PEGA | Common stock | Sale | $323,206 | -5,586 | -4% | $57.86 | 132,619 | 05 Dec 2025 | Direct | F2 |
| transaction | PEGA | Common stock | Sale | $57,638 | -998 | -0.75% | $57.75 | 131,621 | 05 Dec 2025 | Direct | F3 |
| transaction | PEGA | Common stock | Options Exercise | $0 | +5,222 | +4% | $0.000000 | 136,843 | 07 Dec 2025 | Direct | F1 |
| transaction | PEGA | Common stock | Tax liability | $123,526 | -2,055 | -1.5% | $60.11 | 134,788 | 07 Dec 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PEGA | Restricted Stock Units | Options Exercise | $0 | -4,402 | -10% | $0.000000 | 39,620 | 05 Dec 2025 | Common stock | 4,402 | $0.000000 | Direct | F1, F4 |
| transaction | PEGA | Stock Options | Options Exercise | $0 | -29,240 | -100% | $0.000000 | 0 | 05 Dec 2025 | Common stock | 29,240 | $32.18 | Direct | F5 |
| transaction | PEGA | Stock Options | Options Exercise | $0 | -20,000 | -100% | $0.000000 | 0 | 05 Dec 2025 | Common stock | 20,000 | $31.05 | Direct | F6 |
| transaction | PEGA | Restricted Stock Units | Options Exercise | $0 | -5,222 | -17% | $0.000000 | 26,104 | 07 Dec 2025 | Common stock | 5,222 | $0.000000 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the right to receive, following vesting, one share of the issuer's common stock. |
| F2 | Represents the weighted average of sale prices, ranging from $57.86 to $57.89. The individual has provided the Company, and undertakes to provide to the staff of the Security and Exchange Commission or any security holder of the Company, upon request, full information regarding the number of shares sold at each separate price. |
| F3 | Represents the weighted average of sale prices, ranging from $57.70 to $57.80. The individual has provided the Company, and undertakes to provide to the staff of the Security and Exchange Commission or any security holder of the Company, upon request, full information regarding the number of shares sold at each separate price. |
| F4 | This restricted stock unit award vested 25% on the Date Exercisable in Table II, with the remaining 75% vesting in equal quarterly amounts over the remaining 3 years. |
| F5 | This stock option is fully vested. |
| F6 | On March 5, 2024, the reporting person was granted an option to purchase 80,000 shares of common stock. The option vests in two installments, with up to 25% to vest on the Date Exercisable in Table II based on Pegasystems' satisfaction of certain performance criteria for the fiscal year ended December 31, 2024, and with up to 75% to vest on the second anniversary of the date of grant based on Pegasystems' satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. The performance criteria for the fiscal year ended December 31, 2024 were met in full, resulting in vesting of the option as to 20,000 shares. |